SynAct Pharma AB

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: SE0008241491

SEK

20.45

-0.2 (-0.97%)

Dec 04

OME

Click here to see other stocks

Company CV

About SynAct Pharma AB

stock-summary

SynAct Pharma AB

Pharmaceuticals & Biotechnology

SynAct Pharma AB is a manufacturer of biological products. The Company is located in Lund, Sweden. It develops medicines for acute impairment in inflammatory diseases. The company's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.

Company Coordinates

Company Details

Scheelevagen 2 , LUND None : 223 63

stock-summary

Tel: 45 28 447567

stock-summary

https://www.synactpharma.com/

stock-summary

Registrar Details

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Board of Directors

Management

Designation

Dr. Torbjorn Bjerke

Chairman of the Board

Mr. Thomas Jonassen

Chief Scientific Officer, Director

Dr. John Haurum

Independent Director

Dr. Terje Kalland

Independent Director

Stock DNA

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-28 Million

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK 1,160 Million ()

P/E

NA (Loss Making)

Industry P/E

NA

Dividend Yield

0.00%

Debt Equity

-0.40

Return on Equity

-54.55%

Price to Book

5.95